Latest News about NVO
Recent news which mentions NVO
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
From Benzinga
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
March 22, 2024
From Motley Fool
Did Eli Lilly Just One-Up Novo Nordisk?
March 22, 2024
From Motley Fool
From InvestorPlace
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health
March 21, 2024
From Benzinga
7 Stocks That Are Creating a Buzz on Wall Street
March 21, 2024
From InvestorPlace
Tickers
NVO
From Motley Fool
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions
March 20, 2024
From Benzinga
3 Biopharma Stocks Predicted to Soar in Q2 2024
March 20, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
From Benzinga
Novo Nordisk Stock Stalls On Oprah TV Special, But Reddit Traders Believe It's 'Not Done Yet'
March 20, 2024
From Benzinga
From Motley Fool
Tesla Investor Ross Gerber Backs Ozempic's Potential To Reduce Monthly Food Expenses — Less Eating, More Saving
March 20, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
From Benzinga
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
March 19, 2024
Tickers
NVO
From Motley Fool
Did Novo Nordisk Just Get a Jump on Eli Lilly?
March 19, 2024
From Motley Fool
From Benzinga
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
March 19, 2024
From Motley Fool
Inconsistent Insurance Coverage For Weight Loss Drugs - Novo Nordisk's GLP-1s Face Hurdles Despite Health Benefits
March 18, 2024
From Benzinga
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
March 18, 2024
From Benzinga
Tickers
NVO
From Motley Fool
Tickers
NVO
From Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
From Motley Fool
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
From Motley Fool
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
March 17, 2024
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.